Barbara E. Thalenfeld is VP & Corporate Development at ENZO BIOCHEM INC (ENZ). They have made 1 open-market trade across 1 company since 2007, most recently 2008-02-04.
CIK 0001236358
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENZ | 55,550 | $17K |
Shares reported on the most recent Form 4, priced at the 2008-02-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZ | SELL | 2007-10-26 | 2007-10-30 | $12.48 | $129K | +5.5% | +6.6% | +6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.